Presentation is loading. Please wait.

Presentation is loading. Please wait.

Discriminant Model for Cytologic Distinction of Large Cell Neuroendocrine Carcinoma from Small Cell Carcinoma of the Lung  Rira Hoshi, CT, Noriyuki Furuta,

Published bySuhendra Salim Modified over 5 years ago

Similar presentations

Presentation on theme: "Discriminant Model for Cytologic Distinction of Large Cell Neuroendocrine Carcinoma from Small Cell Carcinoma of the Lung  Rira Hoshi, CT, Noriyuki Furuta,"— Presentation transcript:

1 Discriminant Model for Cytologic Distinction of Large Cell Neuroendocrine Carcinoma from Small Cell Carcinoma of the Lung  Rira Hoshi, CT, Noriyuki Furuta, CT, Takeshi Horai, MD, Yuichi Ishikawa, MD, PhD, Satoshi Miyata, PhD, Yukitoshi Satoh, MD, PhD  Journal of Thoracic Oncology  Volume 5, Issue 4, Pages (April 2010) DOI: /JTO.0b013e3181ce3cdd Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Photomicrographs illustrating cellular arrangement in transbronchial aspiration or histology specimens of LCNEC and SCLC cases. A, Large and three-dimensional clusters are conspicuous in a cytologic smear of an LCNEC case (Papanicolaou stain, ×20); B, tumor nests of an LCNEC case show palisading and Rosette-like formations in a histology specimen (hematoxylin and eosin stain, ×40); C, single cells are conspicuous in the cytologic smear of an SCLC case (Papanicolaou stain, ×20); and D, tumor cells of an SCLC case comprise irregular nests in a histology specimen (hematoxylin and eosin stain, ×40). Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181ce3cdd) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Frequencies of large clusters with tight cohesion in the LCNEC and SCLC groups (n = 55). Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181ce3cdd) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Histograms of cell areas in LCNEC and SCLC groups. Note that about 60% of the SCLC cells fall in the range of less than 120 µm2, as compared with about 25% for LCNEC cells (p < ). Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181ce3cdd) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

5 FIGURE 5 Photomicrographs illustrating single cells and tissue architecture in LCNEC and SCLC cases. A) Tumor cells ≥120 µm2 and/or with prominent nucleoli are evident in a cytologic smear of an LCNEC case (Papanicolaou stain, ×100); B, nests of LCNEC cells are predominantly composed of large tumor cells with abundant cytoplasm and occasional prominent nucleoli (hematoxylin and eosin stain, ×40); C, tumor cells <120 µm2 without prominent nucleoli are evident in a cytologic smear of an SCLC case (Papanicolaou stain, ×100); D, nests of SCLC cells are predominantly composed of small tumor cells with scant cytoplasm without nucleoli (hematoxylin and eosin stain, ×40). Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181ce3cdd) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

6 FIGURE 4 Frequencies of small tumor cells without prominent nucleoli in the LCNEC and SCLC groups (n = 55). Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181ce3cdd) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

7 FIGURE 6 Logistic regression for frequencies of small tumor cells without prominent nucleoli and large clusters with tight cohesion. The scatter plot allows clear separation of LCNEC (•) and SCLC cases (▴) by the calculated discriminant line. Therefore, a discriminant model for LCNEC and SCLC, diagnosing as SCLCs if dots exist in the field above the line and as LCNECs if below the line, was made. All SCLC and LCNEC cases were discriminated correctly with the discriminant model based on logistic regression from cytologic frequencies, and sensitivity, specificity, and accuracy were all 100%. Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181ce3cdd) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

8 FIGURE 7 Leave-one-out cross validation. Regarding each case as a new case, prediction of the error rate of the discriminant model was analyzed. Red dots show error discriminant cases on cross validation. Two of the LCNEC cases and one SCLC case were discriminated in error with the discriminant model, so that the prediction of error rate of the model was Journal of Thoracic Oncology 2010 5, DOI: ( /JTO.0b013e3181ce3cdd) Copyright © 2010 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Discriminant Model for Cytologic Distinction of Large Cell Neuroendocrine Carcinoma from Small Cell Carcinoma of the Lung  Rira Hoshi, CT, Noriyuki Furuta,"

Similar presentations

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.
Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas  Alexandre M Ab' Saber, MD, Ledo Mazzei Massoni Neto,

Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas  Alexandre M Ab' Saber, MD, Ledo Mazzei Massoni Neto,
Discriminant Model for Cytologic Distinction of Large Cell Neuroendocrine Carcinoma from Small Cell Carcinoma of the Lung  Rira Hoshi, CT, Noriyuki Furuta,

Discriminant Model for Cytologic Distinction of Large Cell Neuroendocrine Carcinoma from Small Cell Carcinoma of the Lung  Rira Hoshi, CT, Noriyuki Furuta,
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
An 82-Year-Old Woman With Small-Cell Lung Cancer: Relapse After 9 Years or a New Primary?  Martijn R. Groenendijk, MD, Erik Thunnissen, MD, PhD, Bauke.

An 82-Year-Old Woman With Small-Cell Lung Cancer: Relapse After 9 Years or a New Primary?  Martijn R. Groenendijk, MD, Erik Thunnissen, MD, PhD, Bauke.
Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers 

Characteristics and Outcomes of Small Cell Lung Cancer Patients Diagnosed During Two Lung Cancer Computed Tomographic Screening Programs in Heavy Smokers 
Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung Cancer  Rita Nizzoli, PhD, Marcello Tiseo, MD, Francesco.

Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung Cancer  Rita Nizzoli, PhD, Marcello Tiseo, MD, Francesco.
Prospective study of endobronchial ultrasound–guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue.

Prospective study of endobronchial ultrasound–guided transbronchial needle aspiration of lymph nodes versus transbronchial lung biopsy of lung tissue.
Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.

Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.
Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 

Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 
Long-Term Survival in Two Cases of Resected Gastric Metastasis of Pulmonary Pleomorphic Carcinoma  Keiju Aokage, MD, Junji Yoshida, MD, Genichiro Ishii,

Long-Term Survival in Two Cases of Resected Gastric Metastasis of Pulmonary Pleomorphic Carcinoma  Keiju Aokage, MD, Junji Yoshida, MD, Genichiro Ishii,
Timon P. H. Buys, BSc, Sarit Aviel-Ronen, MD, Thomas K

Timon P. H. Buys, BSc, Sarit Aviel-Ronen, MD, Thomas K
Molecular Markers Help Characterize Neuroendocrine Lung Tumors

Molecular Markers Help Characterize Neuroendocrine Lung Tumors
An 82-Year-Old Woman With Small-Cell Lung Cancer: Relapse After 9 Years or a New Primary?  Martijn R. Groenendijk, MD, Erik Thunnissen, MD, PhD, Bauke.

An 82-Year-Old Woman With Small-Cell Lung Cancer: Relapse After 9 Years or a New Primary?  Martijn R. Groenendijk, MD, Erik Thunnissen, MD, PhD, Bauke.
Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer: A Brief Report  Tsu-Hui Shiao, MD, Yih-Leong Chang, MD, Chong-Jen Yu, MD, PhD, Yeun-Chung.

Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer: A Brief Report  Tsu-Hui Shiao, MD, Yih-Leong Chang, MD, Chong-Jen Yu, MD, PhD, Yeun-Chung.
Treatment of Pulmonary Epithelioid Hemangioendothelioma with Bevacizumab  Young Hak Kim, MD, Michiaki Mishima, MD, PhD, Aya Miyagawa-Hayashino, MD, PhD 

Treatment of Pulmonary Epithelioid Hemangioendothelioma with Bevacizumab  Young Hak Kim, MD, Michiaki Mishima, MD, PhD, Aya Miyagawa-Hayashino, MD, PhD 
Electronic Updates for JTO Readers

Electronic Updates for JTO Readers
How I Do It—Optimal Methodology for Multidirectional Analysis of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples  Takahiro Nakajima,

How I Do It—Optimal Methodology for Multidirectional Analysis of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples  Takahiro Nakajima,
Large Cell Neuroendocrine Carcinoma of the Mediastinum with α-Fetoprotein Production  Ken Takezawa, MD, Isamu Okamoto, MD, PhD, Junya Fukuoka, MD, PhD,

Large Cell Neuroendocrine Carcinoma of the Mediastinum with α-Fetoprotein Production  Ken Takezawa, MD, Isamu Okamoto, MD, PhD, Junya Fukuoka, MD, PhD,
MAGE qPCR Improves the Sensitivity and Accuracy of EBUS-TBNA for the Detection of Lymphatic Cancer Spread  Beatrix Cucuruz, MD, Sebastian Dango, MD, Vindi.

MAGE qPCR Improves the Sensitivity and Accuracy of EBUS-TBNA for the Detection of Lymphatic Cancer Spread  Beatrix Cucuruz, MD, Sebastian Dango, MD, Vindi.

Similar presentations

Ads by Google